For the quarter ending 2026-03-28, FORM had $19,401K increase in cash & cash equivalents over the period. $29,769K in free cash flow.
| Cash Flow | 2026-03-28 | 2025-12-27 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net income | 20,384 | 23,218 | 15,656 | 15,487 |
| Depreciation and amortization | 9,172 | 9,428 | 11,110 | 17,051 |
| Accretion of discount on investments | - | 1,975 | - | - |
| Reduction in the carrying amount of right-of-use assets | 1,566 | 1,652 | 1,635 | 3,593 |
| Stock-based compensation expense | 8,063 | 9,873 | 9,516 | 19,187 |
| Deferred income tax benefit | -1,136 | -1,924 | 6,490 | -2,639 |
| Gain on sale of business | - | 103 | - | - |
| Provision for excess and obsolete inventories | 4,804 | 4,931 | 3,227 | 6,695 |
| Amortization | - | - | - | 1,339 |
| Restructuring charges | - | - | -41 | 2,160 |
| Acquired inventory step-up amortization | - | 0 | - | - |
| Gain on sale of business and assets | - | - | 0 | 103 |
| Non-cash restructuring charges | - | 2,119 | - | - |
| Restructuring charges | 15,994 | - | - | - |
| Income from equity investment | 1,517 | 290 | 1,168 | -3,484 |
| Foreign currency transaction losses | - | -2,110 | - | - |
| Other than temporary impairment on debt receivable | - | 0 | - | - |
| Other adjustments to reconcile net income to net cash provided by operating activities | 796 | - | 685 | -1,456 |
| Accounts receivable | 7,014 | -7,916 | 18,502 | 9,570 |
| Inventories | 7,428 | 6,751 | 1,545 | 12,367 |
| Prepaid expenses and other current assets | 5,743 | -5,261 | -1,190 | 5,717 |
| Other assets | -32 | 414 | 529 | -460 |
| Accounts payable | 7,525 | -11,381 | -3,950 | 9,649 |
| Accrued liabilities | -5,264 | 5,597 | 3,413 | -4,409 |
| Other liabilities | - | 2,258 | - | - |
| Deferred revenues | - | 4,489 | - | - |
| Other liabilities | 793 | - | -1,891 | 2,487 |
| Deferred grant | - | 0 | - | - |
| Deferred revenues | -207 | - | 5,055 | 1,133 |
| Operating lease liabilities | -1,872 | -2,010 | -2,021 | -4,032 |
| Net cash provided by operating activities | 44,961 | 45,975 | 26,991 | 42,432 |
| Acquisition of property, plant and equipment | 15,192 | 11,313 | 7,505 | 84,840 |
| Acquisition of business, net of cash acquired | - | 20,580 | - | - |
| Proceeds from sale of assets | 76 | 0 | 0 | 103 |
| Purchase of equity investment | 0 | 0 | 0 | 67,156 |
| Purchases of marketable securities | -58,268 | - | 21,555 | 73,823 |
| Purchase of promissory note receivable | - | 0 | 0 | - |
| Purchases of marketable securities | - | 126,307 | - | - |
| Proceeds from maturities and sales of marketable securities | 28,819 | 27,849 | 35,778 | 62,503 |
| Net cash used in investing activities | -23,407 | -34,973 | 6,718 | -163,213 |
| Proceeds from issuances of common stock | 5,836 | 0 | 4,543 | 21,576 |
| Purchase of common stock through stock repurchase program | 0 | 0 | 1,658 | 24,586 |
| Tax withholdings related to net share settlements of equity awards | 6,751 | 3,793 | 4,990 | 3,619 |
| Payments on term loan | 281 | 280 | 277 | 549 |
| Net cash used in financing activities | -1,196 | -4,073 | -2,382 | -7,178 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -957 | -993 | -1,121 | 1,658 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 19,401 | 5,936 | 30,206 | -126,301 |
| Cash, cash equivalents and restricted cash, beginning of year | 107,047 | 101,111 | 197,206 | - |
| Cash, cash equivalents and restricted cash, end of period | 126,448 | 107,047 | 101,111 | - |
FORMFACTOR INC (FORM)
FORMFACTOR INC (FORM)